6.85
6.85 (-2.03%)
As of Mar 06, 2024
Alector Inc [ALEC]
Source:
Company Overview
Alector, Inc is a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | (415) 231-5660 |
| Industry | manufacturing |
| CEO | Arnon Rosenthal |
| Website | www.alector.com |